All News Xencor, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-11 pm EDT			5-day change	1st Jan Change
21.94 ^USD	+0.23%		-6.60%	+3.34%

May. 15	Transcript : Xencor, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM
May. 10	Wedbush Adjusts Xencor's Price Target to $36 From $34, Keeps Outperform Rating	MT

The Appeals Review Panel's In Re Xencor Decision: The USPTO Provides Its Position On Written Description And Means-Plus-Function Claims	May. 24	AQ
Transcript : Xencor, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM	May. 15
Wedbush Adjusts Xencor's Price Target to $36 From $34, Keeps Outperform Rating	May. 10	MT
Xencor: Q1 Earnings Snapshot	May. 09	AQ
Earnings Flash (XNCR) XENCOR Reports Q1 Revenue $12.8M	May. 09	MT
Xencor Reports First Quarter 2024 Financial Results	May. 09	BU
Xencor, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
BTIG Cuts Price Target on Xencor to $38 From $56, Keeps Buy Rating	Apr. 16	MT
Xencor Names Bart Cornelissen as Chief Financial Officer	Apr. 09	MT
Xencor Appoints Bart Cornelissen as Chief Financial Officer	Apr. 09	BU
Xencor, Inc. Announces CFO Changes	Apr. 09	CI
Xencor Appoints Bart Cornelissen as Senior Vice President	Apr. 09	CI
USTPO Issues Means-Plus-Function Memorandum	Mar. 27	AQ
Transcript : Xencor, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 11:15 AM	Mar. 14
Xencor Insider Sold Shares Worth $293,519, According to a Recent SEC Filing	Mar. 07	MT
North American Morning Briefing : Fed's Preferred -2-	Feb. 29	DJ
Xencor to Present at Upcoming Investor Conferences	Feb. 28	BU
Wedbush Adjusts Xencor's Price Target to $34 From $36, Keeps Outperform Rating	Feb. 28	MT
Transcript : Xencor, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Xencor: Q4 Earnings Snapshot	Feb. 27	AQ

No results for this search